Where is Abbott Laboratories's revenue disclosed?
The figure, the filing and period it comes from, and the reported definition.
The answer
$44.33B
Revenue, fiscal year ending Dec 31, 2025
Document: 10-K filed 2026-02-20 (accession 0001628280-26-010185)
Reported as XBRL element RevenueFromContractWithCustomerExcludingAssessedTax (Revenue from Contract with Customer, Excluding Assessed Tax).
Definition: Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Calculation: none — the value is reported directly.
Source register
| Period end | Value | Form | Filed | Accession |
|---|---|---|---|---|
| Dec 31, 2018 | $30.58B | 10-K | 2021-02-19 | 0001104659-21-025751 |
| Dec 31, 2019 | $31.90B | 10-K | 2022-02-18 | 0001104659-22-025141 |
| Dec 31, 2020 | $34.61B | 10-K | 2023-02-17 | 0001628280-23-004026 |
| Dec 31, 2021 | $43.08B | 10-K | 2024-02-16 | 0001628280-24-005348 |
| Dec 31, 2022 | $43.65B | 10-K | 2025-02-21 | 0001628280-25-007110 |
| Dec 31, 2023 | $40.11B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2024 | $41.95B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2025 | $44.33B | 10-K | 2026-02-20 | 0001628280-26-010185 |